Cargando…
EPA guidance on treatment of negative symptoms in schizophrenia
Negative symptoms of schizophrenia remain a major therapeutic challenge. The progress in the conceptualization and assessment is not yet fully reflected by treatment research. Nevertheless, there is a growing evidence base regarding the effects of biological and psychosocial interventions on negativ...
Autores principales: | Galderisi, S., Kaiser, S., Bitter, I., Nordentoft, M., Mucci, A., Sabé, M., Giordano, G. M., Nielsen, M. Ø., Glenthøj, L. B., Pezzella, P., Falkai, P., Dollfus, S., Gaebel, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057437/ https://www.ncbi.nlm.nih.gov/pubmed/33726883 http://dx.doi.org/10.1192/j.eurpsy.2021.13 |
Ejemplares similares
-
EPA guidance on assessment of negative symptoms in schizophrenia
por: Galderisi, S., et al.
Publicado: (2021) -
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022) -
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022) -
EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination
por: Gaebel, W., et al.
Publicado: (2020) -
An EPA for better Bedside Teaching
por: van Dam, Marjel, et al.
Publicado: (2021)